Comments
Loading...
Galapagos (GLPG) Forecast
NewsEarningsGalapagos (GLPG) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGalapagos (NASDAQ:GLPG) Stock Quotes, Forecast and News Summary
Galapagos Stock (NASDAQ: GLPG) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Galapagos (GLPG) stock?
You can purchase shares of Galapagos (NASDAQ:GLPG) through any online brokerage.
Who are Galapagos (GLPG) competitors?
Other companies in Galapagos’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), 89bio (NASDAQ:ETNB), Syndax Pharmaceuticals (NASDAQ:SNDX), Arcutis Biotherapeutics (NASDAQ:ARQT) and Mesoblast (NASDAQ:MESO).
What is the forecast, or price target, for Galapagos (GLPG) stock?
Galapagos has a consensus price target of $39.13.
What is the current price for Galapagos (GLPG)?
The stock price for Galapagos (NASDAQ: GLPG) is $26.67 last updated February 24, 2025 at 2:22 PM EST.
Does Galapagos (GLPG) pay a dividend?
There are no upcoming dividends for Galapagos.
When is Galapagos (NASDAQ:GLPG) reporting earnings?
Galapagos’s Q1 earnings are confirmed for Friday, May 2, 2025.
Is Galapagos (GLPG) going to split?
There is no upcoming split for Galapagos.
What sector and industry does Galapagos (GLPG) operate in?
Galapagos is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.